Maeyama JI - Search Results

1

Lipid phenotype of two distinct subpopulations of Mycobacterium bovis Bacillus Calmette-Guerin Tokyo 172 substrain.

Naka T, Maeda S, Niki M, Ohara N, Yamamoto S, Yano I, Maeyama JI, Ogura H, Kobayashi K, Fujiwara N. Naka T, et al. Among authors: maeyama ji. J Biol Chem. 2011 Dec 23;286(51):44153-44161. doi: 10.1074/jbc.M111.310037. Epub 2011 Oct 26. J Biol Chem. 2011. PMID: 22030395 Free PMC article.

2

Effects of recombinant cholera toxin b subunit (rCTB) on cellular immune responses: enhancement of delayed-type hypersensitivity following intranasal co-administration of Mycobacterium bovis-BCG with rCTB.

Maeyama J, Isaka M, Yasuda Y, Matano K, Morokuma K, Ohkuma K, Tochikubo K, Yamamoto S, Goto N. Maeyama J, et al. Microbiol Immunol. 2004;48(6):457-63. doi: 10.1111/j.1348-0421.2004.tb03536.x. Microbiol Immunol. 2004. PMID: 15215619 Free article.

3

The mucosal adjuvanticity of the oligodeoxynucleotides containing a non-methylated CpG motif on BCG and diphtheria toxoid.

Maeyama J, Komiya T, Takahashi M, Isaka M, Goto N, Yamamoto S. Maeyama J, et al. Vaccine. 2009 Feb 18;27(8):1166-73. doi: 10.1016/j.vaccine.2008.12.025. Epub 2009 Jan 9. Vaccine. 2009. PMID: 19136040

4

Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG.

Taniguchi K, Takii T, Yamamoto S, Maeyama J, Iho S, Maruyama M, Iizuka N, Ozeki Y, Matsumoto S, Hasegawa T, Miyatake Y, Itoh S, Onozaki K. Taniguchi K, et al. Immun Ageing. 2013 Jun 22;10(1):25. doi: 10.1186/1742-4933-10-25. Immun Ageing. 2013. PMID: 23799936 Free PMC article.

5

A palindromic CpG-containing phosphodiester oligodeoxynucleotide as a mucosal adjuvant stimulates plasmacytoid dendritic cell-mediated T(H)1 immunity.

Maeyama J, Takatsuka H, Suzuki F, Kubota A, Horiguchi S, Komiya T, Shimada I, Murata E, Osawa Y, Kitagawa H, Matsuki T, Isaka M, Yamamoto S, Iho S. Maeyama J, et al. PLoS One. 2014 Feb 24;9(2):e88846. doi: 10.1371/journal.pone.0088846. eCollection 2014. PLoS One. 2014. PMID: 24586411 Free PMC article.

6

CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses.

Tateishi K, Fujihashi K, Yamamoto N, Hasegawa H, Ainai A, Sato K, Iho S, Yamamoto S, Maeyama JI, Odagiri T, Asanuma H. Tateishi K, et al. Among authors: maeyama ji. Vaccine. 2019 Aug 23;37(36):5382-5389. doi: 10.1016/j.vaccine.2019.07.032. Epub 2019 Jul 22. Vaccine. 2019. PMID: 31345642

7

Comparative Study of the Susceptibility to Oxidative Stress between Two Types of Mycobacterium bovis BCG Tokyo 172.

Taniguchi K, Hayashi D, Yasuda N, Nakayama M, Yazawa K, Ogawa S, Miyatake Y, Suda S, Tomita H, Tokuda M, Itoh S, Maeyama JI, Ohara N, Yamamoto S, Hida S, Onozaki K, Takii T. Taniguchi K, et al. Among authors: maeyama ji. mSphere. 2021 Mar 10;6(2):e00111-21. doi: 10.1128/mSphere.00111-21. mSphere. 2021. PMID: 33692195 Free PMC article.

8

Evaluation of a booster tuberculosis vaccine containing mycobacterial DNA-binding protein 1 and CpG oligodeoxynucleotide G9.1 using a Guinea pig model that elicits immunity to Bacillus Calmette-Guérin.

Maeyama JI, Iho S, Suzuki F, Hayashi D, Yamamoto T, Yamazaki T, Goto Y, Ozeki Y, Matsumoto S, Yamamoto S. Maeyama JI, et al. Tuberculosis (Edinb). 2021 May;128:102067. doi: 10.1016/j.tube.2021.102067. Epub 2021 Mar 4. Tuberculosis (Edinb). 2021. PMID: 33752142

9

Recombinant mycobacterial DNA-binding protein 1 with post-translational modifications boosts IFN-gamma production from BCG-vaccinated individuals' blood cells in combination with CpG-DNA.

Ozeki Y, Yokoyama A, Nishiyama A, Yoshida Y, Ohara Y, Mashima T, Tomiyama C, Shaban AK, Takeishi A, Osada-Oka M, Yamaguchi T, Tateishi Y, Maeyama JI, Hakamata M, Moro H, Kikuchi T, Hayashi D, Suzuki F, Yamamoto T, Iho S, Katahira M, Yamamoto S, Matsumoto S. Ozeki Y, et al. Among authors: maeyama ji. Sci Rep. 2024 Apr 21;14(1):9141. doi: 10.1038/s41598-024-58836-8. Sci Rep. 2024. PMID: 38644371 Free PMC article.

10

An improved abnormal toxicity test by using reference vaccine-specific body weight curves and histopathological data for monitoring vaccine quality and safety in Japan.

Mizukami T, Masumi A, Momose H, Kuramitsu M, Takizawa K, Naito S, Maeyama J, Furuhata K, Tsuruhara M, Hamaguchi I, Yamaguchi K. Mizukami T, et al. Biologicals. 2009 Jan;37(1):8-17. doi: 10.1016/j.biologicals.2008.07.007. Epub 2008 Sep 20. Biologicals. 2009. PMID: 18805705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters